{{Rsnum
|rsid=849530
|Gene=NRP2
|Chromosome=2
|position=205691080
|Orientation=minus
|GMAF=0.4559
|Gene_s=NRP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 22.1 | 51.3 | 26.5
| HCB | 5.9 | 40.0 | 54.1
| JPT | 9.8 | 51.8 | 38.4
| YRI | 48.3 | 42.7 | 9.1
| ASW | 38.6 | 40.4 | 21.1
| CHB | 5.9 | 40.0 | 54.1
| CHD | 0.9 | 33.3 | 65.7
| GIH | 7.0 | 42.0 | 51.0
| LWK | 37.3 | 52.7 | 10.0
| MEX | 26.3 | 47.4 | 26.3
| MKK | 50.6 | 42.2 | 7.1
| TSI | 36.3 | 35.3 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23613720
|Title=Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}